The T cell receptor. (TCR) junctional regions (N regions) of the common human Vy9 and V62 gene segments were sequenced from the blood and lung of normal individuals (195 transcripts) and a group of individuals with sarcoidosis (220 transcripts), a granulomatous disease in which increased numbers of Vy9+ -y/b+ T cells are often observed. In normal individuals, the vast majority (86%) ofblood Vy9 transcripts used the JyP gene segment. In contrast to this restriction ofJ region usage, there was a large diversity of the junctional region, with <20% of blood Vy9 junctional regions showing identical sequences for any one normal individual. For the blood V62 transcripts in normal individuals, there was restriction of J region usage, with 93% using J61. The junctional regions were even more diverse than for Vy9, with a unique sequence observed in each transcript examined. Compared with blood, sequences from the normal lung showed a small increase in identical junctional regions, particularly in.one individual where 46% of Vy9 transcripts examined were identical, suggesting a response of some y/6 T cells to antigens found in the lung in the normal state . In marked contrast to normals, some individuals with sarcoidosis had large numbers of Vy9 transcripts, as well as VS2 transcripts, sharing identical sequences . For Vy9 blood transcripts, two individuals showed 84 and 56% ofjunctional region sequences to be identical, respectively. Similarly, blood VS2 transcripts showed 43, 33, and 25% identical junctional region sequences in three individuals . In the sarcoid patient with the most striking over-representation of blood Vy9junctional sequences, lung Vy9 transcripts showed increased (67%) use of the same junctional region sequence as in blood. This limited diversity of TCR junctional regions among some individuals with sarcoidosis suggests a response from specific stimuli, possibly antigenic, and that y/6 T cells may play a specific role in granuloma formation in sarcoidosis, as has been suggested in other granulomatous diseases.
The T cell receptor. (TCR) junctional regions (N regions) of the common human Vy9 and V62 gene segments were sequenced from the blood and lung of normal individuals (195 transcripts) and a group of individuals with sarcoidosis (220 transcripts), a granulomatous disease in which increased numbers of Vy9+ -y/b+ T cells are often observed. In normal individuals, the vast majority (86%) ofblood Vy9 transcripts used the JyP gene segment. In contrast to this restriction ofJ region usage, there was a large diversity of the junctional region, with <20% of blood Vy9 junctional regions showing identical sequences for any one normal individual. For the blood V62 transcripts in normal individuals, there was restriction of J region usage, with 93% using J61. The junctional regions were even more diverse than for Vy9, with a unique sequence observed in each transcript examined. Compared with blood, sequences from the normal lung showed a small increase in identical junctional regions, particularly in.one individual where 46% of Vy9 transcripts examined were identical, suggesting a response of some y/6 T cells to antigens found in the lung in the normal state . In marked contrast to normals, some individuals with sarcoidosis had large numbers of Vy9 transcripts, as well as VS2 transcripts, sharing identical sequences . For Vy9 blood transcripts, two individuals showed 84 and 56% ofjunctional region sequences to be identical, respectively. Similarly, blood VS2 transcripts showed 43, 33, and 25% identical junctional region sequences in three individuals . In the sarcoid patient with the most striking over-representation of blood Vy9junctional sequences, lung Vy9 transcripts showed increased (67%) use of the same junctional region sequence as in blood. This limited diversity of TCR junctional regions among some individuals with sarcoidosis suggests a response from specific stimuli, possibly antigenic, and that y/6 T cells may play a specific role in granuloma formation in sarcoidosis, as has been suggested in other granulomatous diseases.
T lymphocytes recognize antigens through the TCR, a CD3-associated heterodimeric surface complex that defines the specificity of the T cell (1-3). In normal individuals, most (>90%) ofblood T cells express a TCR composed of a and 0 chains, proteins defined by a large repertoire of genetic elements that recombine during T cell ontogeny, permitting a broad diversity of antigen recognition (1-3) . The remaining T cells have TCRs composed of y and 6 chains. Although the TCR y/6 uses similar recombination processes, unlike the broad repertoire ofgenetic elements that can potentially define the TCR a/a, the human y/6 repertoires are severely limited, with only eight functional Vy and five Jy segments, and an even smaller number of V, D, and J segments defining the 6 locus (4, 5) . Further, in normal individuals, the usage of TCR-y/6 appears to be even more re-169 stricted, in that >60% of blood y/6+ T cells use Vy9 elements, as detected by the mAb TiyA (6) . In addition, analysis of Vy9+ T cell clones demonstrates that most TCRs using Vy9 are Vy9JyP-Cy1 paired with a 6 chain using the V62 elements (7, 8) . In this context, the diversity of the TCR-y/6 is primarily based on the variable deletion or addition ofnucleotides to thejunctional regions (N regions) during rearrangement of the y and 6 loci (9) (10) (11) .
The reason for the increased representation and association of these specific gene segments is not clear. In the context that <5% of human postnatal thymic y/6+ clones have this pattern of gene usage, it does not appear to result from a restriction ofrecombinational possibilities at the gene level nor a restriction of the protein pairing possibilities of 'Y and 6 chains (12) . Rather, it is consistent with the concept that these cells are exported from the thymus during fetal development and/or are subsequently expanded by restricted antigen recognition or other pressures. Further, put in the setting of data suggesting that y/b+ T cells play a role in the response to mycobacteria and parasites (13) (14) (15) (16) (17) (18) , and can proliferate in response to mycobacterial heat shock proteins (16) (17) (18) , it is conceivable that the extensive usage of Vy9 paired with VS2 elements among normal blood y/b T cells may reflect early post-thymic exposure to classes of antigens such as heat shock proteins, or other developmental pressures to expand T cells with such specificities.
The present study was designed to help understand these concepts by evaluating the sequences of thejunctional segments of Vy9 and VS2 mRNA transcripts in normal individuals and from individuals with sarcoidosis. The relevance of the sarcoidosis group relates to the recent observation that : (a) 35% of individuals with sarcoidosis have increased numbers of y/b+ T cells, and >70% of these cells are TiyA+ (19) ; and (b) sarcoidosis is a systemic granulomatous disorder for which the etiology is unknown, but has long been considered to relate in some fashion to mycobacteria and/or similar microorganisms (20) . By analyzing a total of 281 Vy9 transcripts and 134 VS2 transcripts of normals and individuals with sarcoidosis, we observed a broad diversity of Vy9 junctional sequences in the normals, but a striking overrepresentation of specific junctional region sequences in a subgroup of the individuals with sarcoidosis . Further, thejunctional regions o£ VS2 transcripts in these same sarcoid individuals also showed an overrepresentation of certain sequences, although less than with Vy9, suggesting the TiyA+ T cells observed in these individuals are expanded post-thymically in response to specific pressures.
Materials and Methods
Source of T Lymphocytes. Two populations of individuals were evaluated: normals and individuals with sarcoidosis. The normals included nine individuals (referred to as "normal 1;' "normal 2;' etc.; with the individual cDNA clones defined as N1 . . , N2. . , respectively) . Five individuals were used as a source of blood T cells and four for lung T cells. None had a history of lung disease, and all had normal chest x-rays and lung function . Bronchoalveolar lavage of four normals showed a normal number of cells recovered and normal cell differential (21) . The patients with sarcoidosis included five individuals diagnosed as previously described (22) . All had pulmonary sarcoidosis as diagnosed by an intrathoracic biopsy showing noncaseating granulomata . The average age was 38 ± 5 yr (all data are presented as mean ± SEM, and all statistical comparisons were made using the two-tailed student's t test). There were four males and one female ; three were nonsmokers, two were ex-smokers . None was receiving therapy at the time of evaluation or within the previous two mo. All had chest x-rays with diffuse reticulonodular infiltrates and hilar adenopathy, and all had positive gallium-67 scans. Lung function tests (23) revealed vital capacity 64 ± 18% predicted, total lung capacity 79 t 6% predicted, ratio of forced expiratory volume in 1 s to forced vital capacity 106 ± 10% predicted, and diffusing capacity 66 ± 7% predicted. As is typical for such individuals, bronchoalveolar lavage analysis revealed an elevation of the average proportion of lymphocytes (37 ± 11%) and the ratio of CD4' (helper/inducer T cells) to CD8' 17 0 Diversity of Vy9 ana VS2 Junctional Sequences (suppressor/cytotoxic T cells) T cells (10.3 ± 6.5). The CD4'/ CD8' ratio for the blood T cells in the same individuals was 1.5 0.8 (24) . Blood mononuclear cells were obtained from heparinized blood by Ficoll-Hypaque (LSM ; Organon Teknika Corp., Durham, NC) gradient centrifugation . Lung mononuclear cells were obtained from bronchoalveolar lavage fluid as previously described (21) . The recovery of lung mononuclear cells was 15 ± 6 x 106 for the normals and 63 ± 14 x 106 for the individuals with sarcoidosis.
mAbs and Flow Cytometry. The phenotype of blood and lung T cells was determined by two-color immunofluorescence and flow cytometry (FRCS 440; Becton Dickinson & Co., Mountain View, CA) with the mAbs Leu-4 (CD3, pan T cell, PE conjugated) ; Leu-3 (CD4, FITC conjugated) ; Leu-2 (CD8, FITC conjugated) ; TCR-1 (WT31, all a/a+ T cells, FITC conjugated) (25) ; (all these mAbs were from Becton Dickinson & Co.) ; TCRS1 (all y/S' T cells, FITC-conjugated; T Cell Sciences, Cambridge, MA) (26) ; TCS-61 (a V61/JSl determinant, 1`11C-conjugated, T Cell Sciences) (27) ; TiyA (recognizing a Vy9-encoded epitope of y/S+ T cells; kindly provided by T Hercend, Institut Gustave-Roussy, Villejuif, France) (28) . Indirect immunofluorescence was performed by using FITCconjugated goat anti-mouse Ig (Becton Dickinson & Co.) as a second antibody. Control antibodies included isotype-matched PEconjugated, FITC-conjugated, and unconjugated nonrelevant mouse myeloma antibodies (control FITC, control PE, control Ig; Becton Dickinson & Co .) .
Analysis ofVy9 and V62 mRNA Transcripts . Total cellular RNA from blood or lung mononuclear cells was extracted using the guanidine/cesium chloride method (29) . Briefly, the cells were lysed as a pellet in 5.5 M guanidine isothiocyanate with 0.5% (vol/vol) 2-ME . The lysates were layered on a cushion of 5.7 M cesium chloride, 100 mM EDTA, and the RNA was collected after centrifugation (180,000 g, 12 h, 20°C) . The pellet was dissolved in 10 mM Tris-HCI, pH 7.4, 5 mM EDTA, and 1% SDS, precipitated with ethanol, then redissolved in water with an RNaseinhibitor (RNasin; Promega Biotec, Madison, WI), and stored in liquid nitrogen vapor until use. When small numbers of lymphocytes were evaluated, as in the case of the normal lung, cytoplasmic RNA was extracted as follows. Cells were suspended in 200 ul of 10 mM Tris-HCI, pH 7.5, 10 mM NaCl, 3 MM MgCl2 with RNasin . Then, 20 Al of 10% NP-40 was added. The mixture was vortexed, and after centrifugation (12,000 g, 5 min), the supernatant was recovered and mixed with 200 Al of 1% SDS, 20 mM EDTA, pH 7.5, 0.6 M NaCl, 20 mM Tris-HCI, pH 7.5 . After phenol/chloroform extraction, RNA was ethanol precipitated .
To sequence Vy9 and VS2 mRNA transcripts in the blood and lung T cell RNA preparations, the following strategy was used . First-strand cDNA was synthesized from the extracted RNA by using cloned M-MLV reverse transcriptase (Bethesda Research Laboratory Gaithersburg, MD) and oligo(dT) (1 h, 37°C). Aliquots of the resulting mixture were used as template for amplification by PCR with Taq DNA polymerase (Perkin-Elmer Cetus, Norwalk, CT) using the following primers: for Vy9, a Vy9 primer with a Pstl cutting site (PVG9; TATCTGCCAGGCACTGTCAGA-AAGGAATC-3') and a Cy primer with a SstI cutting site (PCG7; 5'-TAGAGCTCTATGTTCCAGCCTTCTGGAG-3') ; and for VS2, a VS2 primer with a Pstl site (PVD2: 5'-GACTGCAGGAAGACC-CAAGGTAACAC-3') and a CS primer (PCDI; 5'-GTTATCTTG-GATGACACGAG-3'). The reaction was carried out in a 100-JAI volume under recommended conditions for 45 cycles, consisting of denaturation (94°C, 30 s) ; annealing (54°C, 30 s) ; and extension (72°C, 1 min) using a thermal cycler (Perkin-Elmer Cetus) (30) . Amplified products were phenol/chloroform extracted and ethanol precipitated . After digestion of the Vy9 cDNA with Sstl and PstI, and the V62 cDNA with PstI and EcoRl (the amplified CS region includes an EcoRl cutting sequence), respectively, the cDNA was purified by 1.8% agarose gel electrophoresis, and the appropriate sized band was cut out andextracted (Geneclean ; Biol01, LaJolla, CA). The digested, purified cDNA was ligated to M13mp19 plasmids, and plaques containing appropriate inserts were isolated randomly. Sequencing was done by the dideoxy chain termination method with T7 DNA polymerase (Sequenase ; United States Biochemical Corp., Cleveland, OH) and universal primer (31) . Dot Blot Hybridization . To confirm the presence of multiple copies of identical cDNAs in some individuals with sarcoidosis, the relative numbers of specific Vy9-NJyPjunctional region transcripts compared with total Vy9-NJy transcripts was evaluated using allele-specific amplification, followed by dot blot hybridization (32) . After synthesis of first-strand cDNA from the RNA preparations of T cells of normals and individuals with sarcoidosis, PCR was performed with two sets of primers for 25 cycles under the same conditions as described above. An allele-specific amplification primer was constructed according to the specific junctional region sequence of the Vy9 gene (PVNJ9 ; 5'TACGTGGCCTTGTGG-GAACGGGAA3'), identified as being present in abundance in some individuals with sarcoidosis (see Results) . Two combinations of primers were used for PCR amplification, PVG9 and PCG5 (5'-CTGTCTTTATTGGAGGAAAGATAAT3'), and PVNJ9 and PCG5 . The combination of PVG9-PCG5 will amplify all Vy9 mRNA transcripts, while the combination of PVNJ9-PCG5 will amplify only the cDNA that has the specific junctional region sequence of Vy9 mRNA transcripts. Amplified cDNAs were then dot blotted on a nitrocellulose membrane, and-hybridized with a 'zP-labeled 274-bp Cy region cDNA probe. This probe was synthesized by PCR using PCG2 (5'-AACAACTTGATGCAGATG-TTTCC-3') and PCG3 (5'-TCATGTCTGACGATACATCTGTG-3') and purified by electroelution (see Fig. 1 ) . The relative number of Vy9 mRNA transcripts can then be compared visually.
Single Cell Analysis. For single cell analysis of Vy9 mRNA transcripts from sarcoid 1, blood lymphocytes were stained with Leu-4/PE and TCR-6l/FITC, and double positive cells (y/6 T cells) were sorted by FRCS 440 so that each well of a 96-well U-shaped plastic plate contained one cell (33) . RNA was then prepared as described above, and Vy9 transcripts were amplified by PCR.
Results
FACS analysis of the blood and lung T cells of sarcoid individuals showed many with an increase in the proportion of y /6+ T cells (y/S+/CD3+) in blood (47, 27, 23, 59 , and 7% for sarcoids 1-5, respectively). For all sarcoid individuals, the proportions of y/S+ T cells in the lung was <10%, although the increase in lung lymphocyte numbers in these individuals resulted in a total increase in the number of -Y/b+ T cells in the lung compared with normals. Of the sarcoid individuals with >10% y/6+ blood T cells, several showed an increase in TiyA+ T cells (TiyA+/CD3+: 38, 17, and 58%, for sarcoid 1, 2, and 4, respectively). These same individuals had no relative increase in TCS-61+ blood T cells (TCS-61+/CD3+: 1, 11, and 1%, for sarcoid 1, 2, and 4, respectively). Sarcoid 3 could not be tested due to insufficient biologic material .
A total of 415 mRNA transcripts were sequenced, including 281 Vy9 transcripts and 134 VS2 transcripts. For Vy9 tran-
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Tamura et al . scripts, the region sequenced (see Fig. 1 ) included -100 by of the 3' end of Vy9, the N region, the entire Jy region, and -70 by of the 5' end of the Cy region . Because of space limitations, only thejunctional regions are shown in the tables, with the specific Jy segment identified . Likewise, -100 by of the 3' end of VS2, the N region, Db region, N region, entire J6 region, and -70 by of the 5' end of the CS region were sequenced, but only the junctional region is presented in the tables, along with the specific JS region . Also, for both Vy9 and VS2 transcripts, the sequence is indicated as "inframe" (e.g., a potentially productive transcript based on sequence analysis) or not "in-frame" (e.g., likely a nonproductive transcript based on a frame shift such that the Jy or J6 sequence did not correspond to a known genomic Jy or J6 sequence, respectively) (34-40).
Vy9 mRNA Transcripts in Blood T Cells of Normals. A total of 81 Vy9 transcripts were evaluated in blood T cells of five individuals (Table 1) . Of these, 73 (90% of all Vy9 transcripts) were in-frame (i .e., likely productive) sequences. Of the 73 clones with productive sequences, 63 clones (86%) used the JyP gene segment, nine clones (12%) used Jy2, and one clone (2%) used Jyl; no clones used JyPI or Jy2. Each normal showed a few identicaljunctional sequences used in more than one transcript, but the vast majority were different, showing a large diversity in the V7-NJy junctional region sequences. Most of the identicaljunctional regions showed only a nucleotide deletion of the 3' portion of the Vy9 gene segment or the 5' portion of the Jy gene segment with no addition of The clones were sequenced randomly, but for convenience, they are numbered so that identical sequences have consecutive numbers; NIRG1-3, normal individual 1, blood T cells, y chain, clones 1, 2, and 3; NIB.G4, same but clone 4, etc. t In-frame +, true mRNA transcript ; -, nonproductive transcript based on sequence being frame shifted such that the Jy region did not correspond to a known genomic Jy sequences. (Table 2) . Almost all (60 clones, 94%) showed in-frame sequences. In general, the pattern of sequences was similar to that in blood, with a large diversity among the lung sequences . Of the lung Vy9 transcripts with inframe sequences, 37 clones (62%) used the JyP gene segment, 18 used Jy2 (30%), three used JyP2 (5%), two used J-yPl (3%), and none usedJyl . Among each individual, most sequences were unique, but more sequences shared the same junctional regions than that observed in blood of normals. The most striking example was normal 9, who showed six transcripts out of 13 (46%; clones N9L.G1-6) with the same sequence. However, for the other three individuals, at most, 19% (3 of 16, clones N6L.G1-3, normal 6), 16% (3 of 16, clones N7LM-3, normal 7), or 14% (2 of 14 for three sets of clones, normal 8) were identical . Taken together, of the 60 in-frame Vy9 sequences evaluated in the four normals, the most that any one functional sequence was observed was 10% (six clones [N9L.G1-6] for normal 9); this sequence was not observed in any other normal (lung or blood, Tables 1  and 2 ). Vy9 mRNA Transcripts in Blood and Lung T Cells ofIndividuals with Sarcoidosis. For the individuals with sarcoidosis, J'r Sequences shown include the same regions described in Table 1 . ' The clones are numbered in the same fashion as described in Table 1 ; N6L .G1-3, normal individual 6, lung T cells, -y chain, clones 1, 2, and 3, etc. t 16 by of the 5' portion of the Jy2 gene segment was deleted . See Fig . 1 . Most ofVy9 transcripts of blood T cells (100 of 107 clones, 93%) that were in-frame sequences showed use ofJ-yP, while three clones (3%) used Jyl and one clone each usedJy2, Jyl, and Jy2. In sarcoid 1, only two other in-frame sequences were found (other than the identical sequence previously mentioned), indicating overall limited diversity of the Vy9 transcripts. In contrast to sarcoid 1, the other four sarcoidosis individuals showed large overall diversity in the junctional region sequences, i.e., except the identical sequences described above, the rest of the transcripts showed different sequences from each other. As seen in the normal blood, nonproductive Vy9 sequences among the sarcoid blood T cells mainly used the JyP gene segment .
The limitation of the availability of the biological material limited the analysis oflung T cells among the sarcoid individuals. However, for the one individual that could be analyzed (sarcoid 1, the individual with the most dramatic overrepresentation of the sequence 5'-GCCTTGTGGGAACGGG-3' ; see Table 3 ), the lung T cells showed the same dramatic overrepresentation for this junctional region sequence (Table 4) . In this regard, 14 of the 21 clones (67%, all in-frame) had the identical sequence. Of the 21 transcripts analyzed, all but one used the JyP gene segment .
To confirm the presence of a large number of identical Vy9 transcripts in individuals with sarcoidosis compared with normals, the cDNA populations were evaluated by allelespecific amplification using a primer specific for thejunctional region observed in abundance in individuals sarcoid 1 and 2 (Fig. 2) . The same Cy primer, PCG5, was used in combination with either PVG9, a primer for all Vy9 sequences, or PVNJ9, an allele-specific primer with the specific functional region sequence of the Vy9 gene found in patients with sarcoidosis clones SIRG1-26, S2B.Gl-15, S3B.G1-3, S5B.G1, and SIL.Gl-14, and in normal clones N1B.G6 and N5RG1-2 . Consistent with the sequencing data, dot blot hybridization of amplified cDNA from sarcoid 1 showed al-most the same density of the amplified cDNA by the PVNJ9-PCG5 combination as by the PVG9-PCG5 combination in both blood (Fig. 2, lanes 1 and 2) and lung (Fig. 2, lanes  3 and 4) . Sarcoid 2 showed the same result in the blood (Fig.  2, lanes S and 6) . Sarcoid 4, who did not have any transcripts with this specific sequence, showed a marked discrepancy in the density of the total Vy9 transcripts compared with the junctional region-specific transcripts, consistent with the finding that thejunctional region-specific sequence must be rare in this individual (Fig. 2, lanes 7 and 8) . Normal individuals also showed no overrepresentation of this junctional region-specific sequence (Fig. 2, lanes 9-12) .
V62 mRNA Transcripts in Blood T Cells of Normals. A total of 50 V62 transcripts were evaluated in the blood T cells of three normals (Table 5 ). Of these, 44 clones (88%) had in-frame sequences. In the 44 transcripts with in-frame sequences, 41 clones used J61 (93%), three clones used J63 (7%), while none used J62 . All 50 clones showed different junctional region sequences, suggesting marked diversity.
V62 mRNA Transcripts in Blood T Cells ofIndividuals with Sarroidosis. For the individuals with sarcoidosis, 84 V62 clones from four patients were analyzed (Table 6 ). Of these, 81 clones (96%) had in-frame sequences. Among the 81 clones with in-frame sequences, 70 (86%) used J61, 11 (14%) used J63, and none used J62, the same distribution seen in normals. In contrast to normal individuals, however, there were several sequences that were found in two or more clones. Of the 28 transcripts sequenced in sarcoid 1, more than half were overrepresented, with identical sequences observed in seven clones (25%), six clones (21%), and three clones (11%), respectively, although the sequences of the three sets ofclones were all different . In sarcoid 2, 10 of 23 clones (43%) showed the samejunctional sequence, although it was different from that observed in sarcoid 1. Further, six clones (33%) and three clones (17%) out of 18 transcripts in sarcoid 3 showed the samejunctional sequences, respectively, although different from sarcoid 1 or sarcoid 2.
Although a striking overrepresentation of both Vy9 and V62 transcripts was observed in several individuals with sarcoidosis, it was not possible to determine if these overrepresented Vy9 and V62 transcripts were from the same single T cells. We attempted to answer this question by isolating single y/6+ T cells from the blood of sarcoid 1, the individual with the most marked overrepresentation of sequences (Tables 3, 4 , and 6). Of the 24 cells evaluated at the single cell level, eight (33%) showed positive amplification of cDNA using the primers PVG9 and PCG5, the same combination as described above . However, attempts to sequence the amplified cDNAs was unsuccessful, and insufficient biological material was available to repeat the single-cell sorting and subsequent analysis.
Discussion
Although there is evidence that the TCRy/6 can initiate T cell activation and proliferation through recognition of specific antigens (15) (16) (17) (18) , the role of y/6 T cells in health Sequences shown include the same regions described in Table 1 . ' The clones are numbered in the same fashion as described in Sequences shown include the same regions described in Table 1 . " The clones are numbered in the same fashion as described in Table 1 ; S1L .Gl-14, individual with sarcoidosis 1, lung T cells, y chain, clones 1-14, etc.
and disease is not well understood . One conceptual problem in regard to y/S function in antigen recognition relates to the apparent limited diversity of the number of genetic elements that can potentially recombine to direct the synthesis of y and 6 mRNA transcripts (4, 5, 9) . Further, analysis of blood y/S T cells has shown that the choice of y and 6 gene segments that are actually used is limited, with the majority of y/6 T cells using the Vy9 segment (6) (7) (8) . In addition, most rearranged Vy9 gene segments utilize J-yP and Cyl elements and pair with VS2 chains (7, 8) . Thus, the specificity of TCR-y/b must he elsewhere, likely in the functional regions (N regions) between the V and J (for the y chain) and V and D, D and D, and D and J (for the 6 chain). The analysis of 145 Vy9 mRNA transcripts and 50 VS2 transcripts from blood and lung of normal individuals in the present study strongly supports this concept . While there was clearly limited diversity in the V and J gene segments used (for Vy9, 86% paired with JyP and 12% with Jy2; for VS2, 93% paired withJ61), broad diversity was observed in the junctional regions . In this regard, for the 81 normal blood Vy9 transcripts, no more than three were identical in any one individual, and two identical transcripts were observed only six times . For the normal lung, the diversity was not quite so broad, but still impressive : of 64 Vy9 normal lung transcripts, 42 different sequences were observed, and except for six transcripts of one individual that were identical, lung T cells of other normals had at most only two or three identical sequences. For the blood VS2 transcripts, an even broader diversity was observed . Of the 50 transcripts evaluated, all were different . Further, comparison of the sequences of the 145 Vy9 and 50 V62 transcripts with the Vy9 and the VS2 transcripts of T cell clones in the literature revealed no identical junctional regions (34) (35) (36) (37) (38) (39) (40) (41) (42) (43) (44) (45) . Taken together, these data support the concept, despite limited genomic diversity, and even further limited actual use of genomic elements observed in normals, that there is large potential for possible diverse antigen recognition through the use of the deletion and addition of junctional sequences .
Although the normal lung showed a broad diversity in junctional regions for Vy9 transcripts, the diversity was some what less than that observed in blood . Several possibilities could explain this observation. First, the lung Vy9 transcripts were from T cells recovered from the pulmonary epithelial surface, a location that is in contact with the external environment, and thus, many antigens i .e., the small increase of identical transcripts observed among lung T cells, might result from antigen-driven expansion of some y/S T cells within Figure 2 . Relative number of total Vy9 transcripts compared with Vy9 transcripts containing a specific N region (functional region) sequence observed in high abundance among Vy9 transcripts of some individuals with sarcoidosis . Comparisons were made by allele-specific amplification of cDNA using Vy9 specific primers and N region-specific primers. The primer combination of PVG9 and PCG5 was used for total Vy9 amplification (indicated by V above lanes), while the combination of PVNJ9 and PCG5 was used for N region-specific amplification (indicated by N above lanes) . Amplified cDNAs were evaluated by dot blot hybridization with a 32P-labeled Cy probe (location indicated by closed bar ["probe')) located in Cy exon I (Cy I) where there is a shared sequence between Cyl and Cy2. Sarcoids 1, 2, and 4 and normals 1 and 2 ; two correspond to the individuals thus numbered in the text and tables. Lane 1, Vy9-specific transcripts in blood of sarcoid 1 ; lane 2, N region-specific transcripts in blood of sarcoid 1; lane 3, Vy9-specific transcripts in the lung of sarcoid 1; lane 4, N region-specific transcripts in the lung of sarcoid 1; lane S, Vy9-specific transcripts in the blood of sarcoid 2; lane 6, N region-specific transcripts in blood of sarcoid 2; lane 7, Vy9-specific transcripts in blood of sarcoid 4 ; lane 8, N region-specific transcripts in blood of sarcoid 4 ; lane 9, Vy9-specific transcripts in blood of normal 1 ; lane 10, N region-specific transcripts in lung of normal 1; lane 11, Vy9-specific transcripts in blood of normal 2 ; lane 12, N region-specific transcripts in blood of normal 2 . the lung. In this context, for other sites exposed to the environment, limitedjunctional region diversity has been observed among y/b T cells in BALB/c mouse skin, although not in mouse intestinal epithelium (46) . It is also relevant, in light of recent reports of y/6 T cells responding to mycobacterial antigens, that the lung is a common site for mycobacterial disease. Second, there is evidence that normal lung T cell populations differ from blood T cells in regards to their relative state of differentiation . For example, -90% of normal lung a/ß T cells are CD45RO+ (detected by the mAb Sequences shown include the 3' region of the V62 element (V), the N region (N-D-N-D-N), the 5' region of the J6 element (J), and the specific J6 element (16) . " The clones are numbered in the same fashion as described in Table 1 ; NlB .D1, normal individual 1, blood T cells, 6 chain, clone 1, etc .
UCHL1) (47), a surface antigen observed in antigen-primed memory T cells, suggesting that many T cells on the pulmonary epithelial surface have been exposed to specific antigens. If this is also true for the normal lung y/6 T cell, it would not be surprising to have less diversity among the lung y/6 population compared with blood . The broad diversity ofjunctional sequences among Vy9 and V62 transcripts in normals is in marked contrast to the limited diversity observed in some individuals with sarcoidosis. For Vy9, this was particularly striking for two of five individuals evaluated, in which 84 and 56% of the Vy9 transcripts in blood were identical, respectively. Further, for one of these individuals, 67% oflung Vy9 transcripts were identical and identical to those in blood of the same individual. Further, for V62 transcripts, for the same two individuals with sarcoidosis with the striking overrepresentation of specific Vy9 sequences, there was a marked overrepresentation of specific V62 sequences. It is likely, therefore, although it cannot be proven with certainty from the available data, that these 17 8 Diversity of Vy9 and V62 Junctional Sequences Sequences shown include the same regions described in Table 5 . The clones are numbered in the same fashion as described in Table 1 ; SlB .D1-7, individual with sarcoidosis 1, blood T cells, 6 chain, clones 1-7, etc . overrepresented TCR y and 6 chains are present on the same cell, thereby further limiting TCR diversity. In support of this concept are the data that: (a) the number ofoverrepresented sequences is so striking for both Vy9 and V62 ; (b) the y/6+ cells in these patients are predominantly V61 -, and in normals most y/6 T cells that are V61 -are V62+ ; and (c) Vy9 most commonly pairs with V62 in normals (7, 8) .
Since the data in this study were developed from RNA pooled from many cells before PCR, theoretically, one problem TGTGAC  TGTCAGTCCGCCTTCCTTCATTTACTGG  GGGATTTGAT  ACCGATAAA  J1   15  2  S4BM-2  TGTGAC  CCTCTAGACAACCC  TAAA  J1  +  2  S4B.D3-4  TGTGAC  TCGAACTGGGGGATAGGACGT  TCCTGGGAGA  J3  +  1  S48M  TGTGAC  CCAGTACTOGOGGATACGCCACCCGGCT ACACCGATAAA  J1  +  1  S4B .D6  TGTGAC  CCTCTGOCCTGGOOGATATC  CACCGATAAA  J1  +  1  S4B.D7  TGTGA  GAAGATAGGTGTCCGTCGG  GATAAA  J1  +  1  S4B.D8  TGTGAC  TACCTAGGGACAACTTCGT  ACACCGATAAA  J1  +  1  S4B.D9  TGTGAC  CCTCTGGCCTGGGGGATATC  CACCGATAAA  J1  +  1  S4BM0  TGT  TTTCCTCTGGGGGCCC  ACACCGATAAA  J1  +  1  S4BM1  TGTGA  GAAGATAGGTGTCCGTCGG  GATAAA  J1  +  1  SO .=  TGTGACAC  AATOGGGGATACGCTCCGTGG  A  J1  +  1  S4B .D13  TGTGACAC  GGTACTGGGGGCCGACCACAG  CTCCTGGGACA  J3  +  1  S4B.D14  TGTGACAC  GCTGGGGGATACGC  CACCGATAAA  31  -1  S4B .D15  TGTGAC  CTTTGGGACTCAG  CTCCTGGGACA  J3  - in interpreting the data is the possibility of an activated subpopulation of the cells having increased numbers of mRNA transcripts, thereby skewing the results. T cells of theJurkat tumor cell line activated with PMA have a 5-10-fold increase in their number of a and ß mRNA transcripts . We have evaluated this concept in sarcoidosis for the ß chain (48) , and found that in the lung, the numbers of ß chain transcripts is increased approximately threefold compared with blood, i.e., in active pulmonary sarcoid it is the lung T cells that are activated, while the blood T cells are relatively quiescent. This is consistent with a number of studies comparing lung and blood T cells in sarcoidosis (49) (50) (51) (52) . To our knowledge, no data are available on the level of y and S mRNA transcripts in activated T cells compared with resting T cells, and there are no data on whether the y/S lymphocytes are more activated in sarcoidosis patients than in normals . Putting all of the available data together, it is reasonable to conclude that the data in our study from blood, showing the marked overrepresentation of specific Vy9 and VS2 transcripts, are not associated with an overrepresentation of transcripts from activated T cells prejudicing the selection for sequencing. Further, even if the analysis of RNA is taken from sarcoid patients who have an increased number of activated y/S cells compared with the normals, and if y and S chain RNA is increased in this subset ofcells, then, since the stock ofRNA used for PCR for each patient is a random sample of RNA extracted from a larger sample of millions of lymphocytes, the data of overrepresented sequences observed could not be due to a few-fold increase in transcripts due to activation of y/S lymphocytes. The ideal way to prove what percentage of cells have use of the particular y and S transcripts would be to perform single cell analysis of y and S gene expression. We attempted this, but could not obtain material after PCR that could be sequenced . The implications from the data are interesting for the emerging concepts regarding the function of the TCRy/S and for the pathogenesis of sarcoidosis . Most importantly, put in the setting of studies demonstrating that y/S T cells play a role in the response to mycobacteria and parasites (13) (14) (15) (16) (17) (18) , and can proliferate to mycobacterial proteins, including heat shock proteins (16) (17) (18) , it is a reasonable hypothesis that the y/S T cells in sarcoidosis are being used in a specific, possibly antigen-driven immune response against such antigens.
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Further, the limitation ofjunctional region diversity observed in some individuals with sarcoidosis may imply a response to a small number ofepitopes, with, as a result, oligoclonal populations of y/S T cells. While the cause of sarcoidosis is unknown, it is a granulomatous disorder with morphology broadly similar to mycobacterial-induced disease. Further, there is a long history of scattered evidence in the literature of various mycobacteria being cultured from sarcoid tissue, or remnants of mycobacteria observed by EM in biopsy or autopsy specimens (53) (54) (55) . In addition, mycobacterial antigens are not easily degradable, an observation consistent with the specificity of sarcoid individuals for reacting to the KveimSiltzbach "antigen," a very stable crude preparation extracted from sarcoid spleen (56) . Finally, for the one sarcoid individual evaluated in lung and blood, the identical Vy9 sequences were observed in both locations, consistent with the systemic nature of the disorder.
The data presented also have implications for the potential mechanisms by which normal individuals develop and maintain an overrepresentation of Vy9JyP-Cyl and VS2 usage and pairing in the normal y/S T cell repertoire. In the context that this overrepresentation is not seen in human postnatal thymic clones (12), the mechanism is not a restriction of recombinational possibilities at the gene level nor a restriction of the protein pairing of y and S chains. However, it is conceivable that the overrepresentation results from the Vy9/VS2 cells responding and/or proliferating in response to a ubiquitous antigen or ligand . If so, to be consistent with the present study, such Vy9/VS2 T cells would have to recognize the same group of antigens despite the extensive functional regions (N region) diversity of Vy9/VS2 TCR that was observed . Such a circumstance of specific TCR V region expansion, regardless offunctional region sequence, has been observed by "superantigens" such as staphylococcal enterotoxin (57, 58) . Another plausible hypothesis is that the peripheral y/S T cell repertoire is populated by preferential export of Vy9/VS2 T cells from the thymus during fetal development, a concept consistent with the knowledge that in the mouse fetal thymus there is an early population of T cells exported with TCR using a specific Vy/VS-paired combination, although in this instance junctional region diversity is limited (59, 60) .
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